- Home
- NAAS vs HSCS Comparison
NAAS vs HSCS Comparison
Compare NAAS & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAAS
- HSCS
- Stock Information
- Founded
- NAAS 2019
- HSCS 2007
- Country
- NAAS China
- HSCS United States
- Employees
- NAAS N/A
- HSCS N/A
- Industry
- NAAS Other Specialty Stores
- HSCS Medical Specialities
- Sector
- NAAS Consumer Discretionary
- HSCS Health Care
- Exchange
- NAAS Nasdaq
- HSCS Nasdaq
- Market Cap
- NAAS 8.3M
- HSCS 8.7M
- IPO Year
- NAAS 2017
- HSCS 2022
- Fundamental
- Price
- NAAS $2.75
- HSCS $3.35
- Analyst Decision
- NAAS
- HSCS Strong Buy
- Analyst Count
- NAAS 0
- HSCS 2
- Target Price
- NAAS N/A
- HSCS $13.00
- AVG Volume (30 Days)
- NAAS 142.5K
- HSCS 80.2K
- Earning Date
- NAAS 09-05-2025
- HSCS 09-09-2025
- Dividend Yield
- NAAS N/A
- HSCS N/A
- EPS Growth
- NAAS N/A
- HSCS N/A
- EPS
- NAAS N/A
- HSCS N/A
- Revenue
- NAAS $27,534,354.00
- HSCS $4,350.00
- Revenue This Year
- NAAS $378.49
- HSCS $13,968.97
- Revenue Next Year
- NAAS N/A
- HSCS $166.67
- P/E Ratio
- NAAS N/A
- HSCS N/A
- Revenue Growth
- NAAS N/A
- HSCS N/A
- 52 Week Low
- NAAS $1.96
- HSCS $2.36
- 52 Week High
- NAAS $74.40
- HSCS $6.47
- Technical
- Relative Strength Index (RSI)
- NAAS 44.36
- HSCS 44.53
- Support Level
- NAAS $3.04
- HSCS $3.24
- Resistance Level
- NAAS $3.85
- HSCS $3.59
- Average True Range (ATR)
- NAAS 0.32
- HSCS 0.21
- MACD
- NAAS -0.00
- HSCS -0.01
- Stochastic Oscillator
- NAAS 5.31
- HSCS 17.14
About NAAS NaaS Technology Inc.
Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators. wide range of offline services that simplify the daily operations of charging station operators, and of non-charging services such as food and beverage services to station operators.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.